US 11,919,893 B1
7-(4-((5-(2-bromobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl) piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound
Mai Mostafa Khalaf Ali, Al-Ahsa (SA); Hany Mohamed Abd El-Lateef Ahmed, Al-Ahsa (SA); Amer A. Amer, Sohag (EG); and Antar Ahmed Abdelhamid Ahmed, Al-Baha (SA)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Oct. 9, 2023, as Appl. No. 18/483,292.
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 417/12 (2006.01); A61P 29/00 (2006.01)
CPC C07D 417/12 (2013.01) [A61P 29/00 (2018.01)] 11 Claims
 
1. A 7-(4-((5-(2-bromobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound having the formula I:

OG Complex Work Unit Chemistry